These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20012397)

  • 21. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus.
    Kim K; Kim H; Kwon J; Lee S; Kong H; Im SA; Lee YH; Lee YR; Oh ST; Jo TH; Park YI; Lee CK; Kim K
    Phytomedicine; 2009 Sep; 16(9):856-63. PubMed ID: 19303272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensive efforts for future antidiabetic agents].
    Berne C
    Lakartidningen; 2010 Nov 10-16; 107(45):2815-9. PubMed ID: 21179868
    [No Abstract]   [Full Text] [Related]  

  • 23. Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675).
    Haynes NE; Corbett WL; Bizzarro FT; Guertin KR; Hilliard DW; Holland GW; Kester RF; Mahaney PE; Qi L; Spence CL; Tengi J; Dvorozniak MT; Railkar A; Matschinsky FM; Grippo JF; Grimsby J; Sarabu R
    J Med Chem; 2010 May; 53(9):3618-25. PubMed ID: 20405948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent discovery of plant-derived anti-diabetic natural products.
    Hung HY; Qian K; Morris-Natschke SL; Hsu CS; Lee KH
    Nat Prod Rep; 2012 May; 29(5):580-606. PubMed ID: 22491825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thoughts on the progression of type 2 diabetes drug discovery.
    Bhatt HB
    Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes.
    Xia Y; Chackalamannil S; Greenlee WJ; Jayne C; Neustadt B; Stamford A; Vaccaro H; Xu XL; Baker H; O'Neill K; Woods M; Hawes B; Kowalski T
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3290-6. PubMed ID: 21536438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing therapeutic discovery through phenotypic screening of the extracellular proteome using hydrodynamic intravascular injection.
    Baribault H; Majeti JZ; Ge H; Wang J; Xiong Y; Gardner J; Yang L; Gupte J; Gong Y; Pan Z; Cutler G; Kassner P; Tu H; Shan B; Wu X; Li Y
    Expert Opin Ther Targets; 2014 Nov; 18(11):1253-64. PubMed ID: 25287216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile.
    Semple G; Lehmann J; Wong A; Ren A; Bruce M; Shin YJ; Sage CR; Morgan M; Chen WC; Sebring K; Chu ZL; Leonard JN; Al-Shamma H; Grottick AJ; Du F; Liang Y; Demarest K; Jones RM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1750-5. PubMed ID: 22264481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multistep validation process of biomarkers for preclinical drug development.
    Freeman WM; Bixler GV; Brucklacher RM; Lin CM; Patel KM; VanGuilder HD; LaNoue KF; Kimball SR; Barber AJ; Antonetti DA; Gardner TW; Bronson SK
    Pharmacogenomics J; 2010 Oct; 10(5):385-95. PubMed ID: 19997081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a highly visual, simple, and rapid test for the discovery of novel insulin mimetics in living vertebrates.
    Lee J; Jung DW; Kim WH; Um JI; Yim SH; Oh WK; Williams DR
    ACS Chem Biol; 2013 Aug; 8(8):1803-14. PubMed ID: 23725454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of SGLT2: a novel strategy for treatment of type 2 diabetes mellitus.
    Pfister M; Whaley JM; Zhang L; List JF
    Clin Pharmacol Ther; 2011 Apr; 89(4):621-5. PubMed ID: 21346749
    [No Abstract]   [Full Text] [Related]  

  • 32. Bromocriptine for diabetes mellitus type II.
    Valiquette G
    Cardiol Rev; 2011; 19(6):272-5. PubMed ID: 21983314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes mellitus in suncus: EDS (early-onset diabetes in suncus) colony].
    Ohno T; Yoshida F; Namikawa T
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():704-7. PubMed ID: 9513500
    [No Abstract]   [Full Text] [Related]  

  • 34. Future Perspective of Diabetic Animal Models.
    Pandey S; Dvorakova MC
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):25-38. PubMed ID: 31241444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery.
    Pantaleao SQ; Fujii DGV; Maltarollo VG; da C Silva D; Trossini GHG; Weber KC; Scott LPB; Honorio KM
    Med Chem; 2017; 13(8):706-720. PubMed ID: 28530546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Discovery and Development of Type 2 Diabetes Mellitus: Modern-Integrative Medicinal Approach.
    Ghosh D; Parida P
    Curr Drug Discov Technol; 2016; 13(2):60-7. PubMed ID: 27074851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signature: a powerful approach for drug discovery in diabetes.
    Sithara S; Crowley TM; Walder K; Aston-Mourney K
    J Endocrinol; 2017 Feb; 232(2):R131-R139. PubMed ID: 27927696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New lead found to a possible "insulin pill".
    Gura T
    Science; 1999 May; 284(5416):886. PubMed ID: 10357667
    [No Abstract]   [Full Text] [Related]  

  • 39. Repurposing Drugs to Target the Diabetes Epidemic.
    Turner N; Zeng XY; Osborne B; Rogers S; Ye JM
    Trends Pharmacol Sci; 2016 May; 37(5):379-389. PubMed ID: 26900045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond drug discovery: Exploring the physiological and methodological dimensions of zebrafish in diabetes research.
    Roohi TF; Faizan S; Shaikh MF; Krishna KL; Mehdi S; Kinattingal N; Arulsamy A
    Exp Physiol; 2024 Jun; 109(6):847-872. PubMed ID: 38279951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.